The behavior of Influenza A (H1N1) is marked by the increase in the scourge of the virus, the realization of a specialists international meeting and the announced delay in the supply of vaccines in the U.S.A.
The specialists have insisted on the fact that children and pregnant women constitute high risk groups and the importance of applying the medical treatment ASAP against a virus that has already provoked at least 4 735 deceased people and over 399 232 infected ones until September 11th; according to the reports of the WHO.
Compared to the World Health Organization´s last report on October 9th and cited by Europe Press, new 210 deaths have been registered and over 21 009 new people infected by the virus.
These figures indicate a reduction in the number of new deceased- the former report registered 417- and in the amount of infected people- there were 34 925 new cases in the last measuring-, and the number of countries having people infected with the virus remains in 192.
In the American continent 3 406 deceased have been counted (114 more than last week) and 153 697 infected people (7 681 more than last week).
Gregory Hartl, spokesperson from the WHO, pointed out that “… although the deaths rate might not be considered enormous, we must be prepared for any further development as we go through the winter in the Northern hemisphere”.
The data show that cases continue increasing in different areas of the northern hemisphere, and the United States of America goes through a raise in the infection rate, above the season influenza.
At the same time, it was informed that the supply of Influenza A (H1N1) vaccines in the U.S.A. will be delayed since the companies can not make as many doses of it as it was expected, expressed the Centers for Prevention and Disease Control (CDC) last Friday, according to Reuters.
CDC doctor Anne Schuchat stated that although 4 million doses were prospected for the end of October, only 28- 30% of that amount will be available, and she also expressed that in only a few weeks more children have died than they usually do in a full period of season influenza.
At the same time, international preoccupation remains present on how underdeveloped nations will have access to the costly vaccine against the H1N1 virus.
It was also known that before the urgency of the world situation due to this disease, a meeting of WHO specialists was held in Washington to deal with “clinical aspects of human influenza”, according to reports form Notimex.